User profiles for E. Smit

EF. Smit

- Verified email at nki.nl - Cited by 63168

Edith G. Smit

- Verified email at uva.nl - Cited by 11046

Erasmus Smit

- Verified email at heartofengland.nhs.uk - Cited by 4769

Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

…, ST Popat, K Kerr, S Novello, EF Smit… - Annals of …, 2018 - annalsofoncology.org
Primary lung cancer remains the most common malignancy after non-melanocytic skin cancer,
and deaths from lung cancer exceed those from any other malignancy worldwide [1]. In …

Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review

E Vangeli, J Stapleton, ES Smit, R Borland, R West - Addiction, 2011 - Wiley Online Library
Aims To identify the predictors of attempts to stop smoking and the predictors of quit attempt
success in adult general population samples. Methods We performed an electronic search of …

Burden of disability due to musculoskeletal (MSK) disorders

L March, EUR Smith, DG Hoy, MJ Cross… - Best practice & research …, 2014 - Elsevier
This chapter summarises the global and regional prevalence, disability (Years Lived with
Disability (YLDs)) and overall burden (Disability Adjusted Life Years (DALYs)) and costs for the …

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non–small-cell lung cancer

…, R Eek, T Horai, K Noda, I Takata, E Smit… - Journal of clinical …, 2003 - ascopubs.org
Purpose: To evaluate the efficacy and tolerability of two doses of gefitinib (Iressa [ZD1839];
AstraZeneca, Wilmington, DE), a novel epidermal growth factor receptor tyrosine kinase …

Prevalence of specific language impairment in kindergarten children

…, NL Records, P Buckwalter, X Zhang, E Smith… - Journal of speech …, 1997 - ASHA
This epidemiologic study estimated the prevalence of specific language impairment (SLI) in
monolingual English-speaking kindergarten children. From a stratified cluster sample in rural…

[HTML][HTML] Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer

BT Li, EF Smit, Y Goto, K Nakagawa… - … England Journal of …, 2022 - Mass Medical Soc
Background Human epidermal growth factor receptor 2 (HER2)–targeted therapies have
not been approved for patients with non–small-cell lung cancer (NSCLC). The efficacy and …

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled …

…, R Cornelissen, L Heniks, J Hiltermann, E Smit… - The Lancet, 2019 - thelancet.com
Background Most patients with small-cell lung cancer (SCLC) have extensive-stage disease
at presentation, and prognosis remains poor. Recently, immunotherapy has demonstrated …

Introducing COBRAs: Exploring motivations for brand-related social media use

DG Muntinga, M Moorman, EG Smit - International Journal of …, 2011 - Taylor & Francis
Social media websites such as Facebook, YouTube and Twitter provide unlimited means for
internet users to interact, express, share and create content about anything, including …

Real-time, portable genome sequencing for Ebola surveillance

…, MKO Shea, AMD Johnston, D Wilson, E Hutley, E Smit… - Nature, 2016 - nature.com
The Ebola virus disease epidemic in West Africa is the largest on record, responsible for over
28,599 cases and more than 11,299 deaths 1 . Genome sequencing in viral outbreaks is …

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

…, W Timens, H Sietsma, E Thunnissen, E Smit… - Nature …, 2012 - nature.com
Small-cell lung cancer (SCLC) is an aggressive lung tumor subtype with poor prognosis 1 ,
2 , 3 . We sequenced 29 SCLC exomes, 2 genomes and 15 transcriptomes and found an …